Device Discounts and Rebates: The Price Concession That Must Reach the Claim

Whistleblower Justice Network

Medical device discount rebate kickbacks use price concessions to buy purchasing decisions that lead to federal health care claims. The benefit may reach a hospital, a supplier or the physician who influences which device gets used. For an insider, the revealing detail is often what the customer had to do to earn it: place another order, switch a competitor’s business or implant the purchased devices before a deadline. The sales agreement explains the incentive. Purchasing and billing records show where it went.

How a Device Rebate Hides the Real Price

The discount exception in the Anti-Kickback Statute requires a price reduction to be properly disclosed and appropriately reflected in the costs claimed or charges made. A discount recorded in the manufacturer’s sales system still has to reach the buyer’s relevant reporting.

The law reaches both the party offering the benefit and the party receiving it in return for federal-program business. It covers purchases, orders and recommendations as well as referrals. In the device business, that matters because the hospital may sign the purchase order while the surgeon strongly influences the brand and type of implant. The person who chooses the product and the organization that pays for it can be different.

An invoice discount reduces the purchase price on the bill. A rebate arrives later, so its terms and the later payment have to be read together. The discount rules require the seller to set the rebate’s terms and disclose them in writing when the buyer makes the initial purchase.

A rebate negotiated after the sale therefore raises a different issue from a later payment under terms already agreed. The contract, sales instructions and rebate calculation show which arrangement the customer actually received. A commercial explanation for a payment can coexist with an intention to induce business.

For the seller, the relevant information is the benefit offered, the purchases it covers and the terms communicated to the buyer. For the buyer, it is the net cost and how the concession appears in the required cost or charge reporting. We connect those accounts with you, including who understood the deal and who prepared the figures sent onward.

St. Jude’s Alleged Rebate Tied the Saving to Another Order

St. Jude Medical paid $3,725,000 in the June 2010 resolution of allegations involving retroactive rebates and rebates on competitor products used to secure device business. Parma Community General Hospital and Norton Healthcare also paid settlements. The purchasing side of the transaction was part of the case alongside the manufacturer.

The whistleblower’s amended complaint describes a proposed rebate to Parma on implantable defibrillators:

That same year, St. Jude offered Parma a similar rapid rebate proposal, pursuant to which the hospital would receive a rebate of $400 per ICD on the hospital’s entire quantity purchase if the items were implanted within 60 days of receipt and a commitment for another quantity purchase order was placed prior to the end of the same quarter.

United States ex rel. Hudson v. St. Jude Medical, Inc., whistleblower’s amended complaint, paragraph 48

Under the alleged deal, the hospital earned its saving by getting devices into patients before the sales deadline and committing to another order. Someone reviewing only the final purchase price would miss the conditions that earned it.

The same complaint alleged that customers could lose access to research equipment if they refused to commit to additional device sales. Equipment placement and a price concession could each serve the same purchasing objective.

How Does Reimbursement Work for Medical Devices?

Medicare usually pays for the hospital stay or procedure with the implanted device included. Hospital outpatient payment packages implantable devices into the service payment, inpatient payment absorbs their cost into the payment for the stay, and ambulatory surgery centers generally receive a packaged procedure payment.

That gives a hospital a reason to negotiate down its acquisition cost. The purchase price, the net cost after a rebate, the hospital’s charge and Medicare’s payment describe different parts of the transaction.

The payment method determines which representation matters. A purchasing ledger can show the price concession, while a cost report or claim shows what the provider told the program. Comparing those records means identifying the payment system first. Treating the invoice, charge and payment as the same number hides the very discrepancy the case needs to explain.

When the Invoice Hides the Agreed Price

A complaint concerning Coloplast illustrates why the invoice alone can be misleading. The whistleblowers alleged that Coloplast, Shield and A-Med used rebates to bring inflated invoice prices down to the prices the parties had actually agreed:

Shield and A-Med and Coloplast would then set up a “rebate” or “chargeback” (collectively referred to as “rebate”) which reduced the amount paid by Shield and A-Med from the artificial and inflated invoice price, down to the true, agreed-upon price.

United States ex rel. Herman v. Coloplast Corp., whistleblower complaint, paragraph 132

The complaint alleged that the volume thresholds were set near or below existing purchasing levels and that the arrangements evaded Medi-Cal billing limits. That alleged mechanism puts the rebate calculation beside the invoice. The higher document price and the lower agreed price were both part of the same transaction. Under those allegations, the suppliers kept the lower price while Medi-Cal, and the taxpayers funding it, paid too much.

Group Purchasing Organization Fees and Hospital Rebates Go to Different Recipients

A group purchasing organization can receive an administrative fee while passing a separate rebate to the purchaser. The purchasing agreement between HealthTrust Purchasing Group and Cardiovascular Systems, effective in August 2014, shows both payments in the same contract.

The vendor owed administrative fees on covered purchases made directly or through a distributor, including separately negotiated purchases. It also had to supply an electronic report listing each purchaser’s purchases with the fee payment. Rebates took a different route through the same organization: the vendor paid HealthTrust, which paid the purchasers.

For a contracting or finance employee, the distinction is practical. A payment to the GPO may compensate the purchasing organization or carry a rebate onward to the hospital. The agreement and purchaser-level reporting identify which. Following only the first recipient stops before the transaction is finished.

The GPO’s annual written disclosures tell each provider member what it received from each vendor on that member’s purchases. Those disclosures connect the fee to the hospital’s buying.

Free Products and Services Can Carry the Price of Switching

A free product can be the inducement to buy another product. Under the discount safe harbor, that arrangement falls outside the discount definition unless the goods or services are reimbursed by the same federal program using the same methodology, with the reduced charge fully disclosed and appropriately reflected in reimbursement.

That makes the connection between the products consequential. A free instrument, capital unit or service belongs beside the purchase it was intended to secure. The economic benefit can sit outside the invoice for the product that generates the healthcare claim.

C.R. Bard’s 2013 civil settlement required $48.26 million to resolve allegations that grants, rebates, conference fees, marketing assistance and free equipment induced purchases of brachytherapy seeds. Several kinds of benefit served the alleged sales objective. Reviewing rebates alone would have captured only part of it.

The Respironics settlement in 2016 concerned free call-center services for durable medical equipment suppliers. According to the allegations, the service was free for patients using Respironics masks, but suppliers paid a monthly fee based on the number using competitors’ masks. The cost of the service changed with the customer’s choice of product.

In the separate ResMed settlement, the alleged benefits included free outreach, discounted masks and equipment, and backing the customer’s interest-free borrowing from a third-party lender. Credit support can carry value even when the manufacturer never sends the customer a check.

A Replacement-Device Credit Follows a Different Transaction

A purchase rebate rewards a buying commitment. A warranty credit follows the replacement of a covered device. The question then becomes whether the manufacturer supplied the credit owed and whether the resulting claim reflected it where required.

Guidant’s September 2011 settlement resolved allegations that it withheld warranty credits or rebates for explanted pacemakers and defibrillators, inflating replacement costs to federal programs. St. Jude’s May 2012 settlement concerned allegations that it withheld warranty credits when billing the Defense and Veterans Affairs departments for replacement devices. That was a direct federal purchasing transaction, distinct from a hospital’s Medicare bill.

The hospital can also be the point where the credit disappears. Medicare reduces payment for qualifying devices supplied free or with a substantial credit. The claim shows the credit only when the hospital reports it. The manufacturer’s credit and the hospital’s reporting therefore need to be examined together.

What Kind of Proof Is Needed to Be a Whistleblower?

Sales proposals, rebate agreements, credit memos and hospital billing records can connect the price concession to the government claim. The proposal shows what was offered; the agreement and rebate records show what the buyer earned. We work with you to connect those terms to the devices used and the amounts reported.

A 2020 paper in the Journal of Forensic and Investigative Accounting puts the claim connection precisely:

The FCA does not attach liability to the underlying fraudulent activity or the government’s wrongful payment, but to the “claim for payment or approval.”

A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, Journal of Forensic and Investigative Accounting, 2020

The transaction reaches beyond the sales department. A hospital claim does not identify the implanted product by its unique device identifier. It can leave the product and its credit history out of view. We connect the invoice, implant record and credit memo with you to explain what the bill leaves out.

We work with insiders who understand why the rebate was offered, who controlled the purchasing choice and what billing was told. If you helped run the rebate program, that is something we work through with you. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When You Know What Earned the Rebate

If you work in device sales, contracting or hospital finance and know the conditions behind a rebate, speak with our whistleblower experts about the deal and the billing. We build the case with you around the purchasing incentive, the money and the government claims, and bring in medical device fraud whistleblower lawyers who understand those connections. We stay beside you from that first account of the arrangement through the case.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365